Europe’s CHMP top scientific committee gave a positive opinion for approval to cladribine, with the proposed trade name Mavenclad, for relapsing forms of MS with high disease activity.

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. Blair, best known for her roles in turn ...

Mavenclad’s list price is £2,047.24 per 10mg tablet – a high price, but one that NHS England will have secured a discount on. In addition the outcomes-based agreement will mean the health ...